Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis
- 23 August 1985
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 254 (8) , 1046-1049
- https://doi.org/10.1001/jama.254.8.1046
Abstract
In a prospective, single-blind, randomized study, a single 2-g dose of metronidazole was compared with a seven-day course of 500 mg given twice daily in the treatment of symptomatic vaginal discharge associated withGardnerella vaginalis. Based on resolution of symptoms and on cultures negative forG vaginalis, 86% (40/46) of women treated with the single dose and 97% (35/36) of women treated with the seven-day course were considered cured at seven to ten days after treatment. Evaluation at 21 days after treatment, however, indicated that only 46% (16/34) of patients treated with the single 2-g dose were considered cured compared with 86% (26/30) of those treated with the seven-day course. Treatment of sexual contacts did not significantly improve cure rates in either group. (JAMA1985;254:1046-1049)This publication has 6 references indexed in Scilit:
- AN EVALUATION OF SINGLE-DOSE METRONIDAZOLE TREATMENT FOR GARDNERELLA VAGINALIS VAGINITIS1984
- Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associationsPublished by Elsevier ,1983
- Rapid Presumptive Identification of Gardnerella vaginalis ( Haemophilus vaginalis ) from Human Blood Agar MediaJournal of Clinical Microbiology, 1981
- Relative Susceptibilities of Gard ne re1 I a vaginal is (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and Its Two Major MetabolitesSexually Transmitted Diseases, 1980
- CORYNEBACTERIUM VAGINALE AND VAGINITIS: A CONTROLLED TRIAL OF TREATMENTThe Lancet, 1980
- Nonspecific VaginitisNew England Journal of Medicine, 1978